They are formed strictly to raise capital through an initial public offering (IPO) that it can then use to acquire or merge with another company. After a period of relative obscurity—they were ...
Hexaware Technologies IPO Allotment: Investors who applied for the IPO can check their allotment status online through the registrar, KFin Technologies, or via the Bombay Stock Exchange (BSE) website.
17d
GlobalData on MSNAardvark prices $94.2m IPO to fund development of Prader-Willi syndrome drugAardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.
Aardvark’s IPO comes amid an uptick in biotech ... far in 2025 include obesity drug developer Metsera, Sionna Therapeutics, kidney disease startup Maze Therapeutics, and Ascentage Pharma.
SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule ...
Shares of APO stock traded down $1.49 during mid-day trading on Friday, reaching $163.39. The company’s stock had a trading volume of 2,484,780 shares, compared to its average volume of ...
SpaceX CEO Elon Musk has no immediate plans to launch an IPO of either entity. Investors interested in the satellite sector can consider stocks like Boeing, Lockheed Martin, or ETFs focused on the ...
Chamunda Electricals IPO: The initial public offer of Chamunda Electricals Ltd, which will be closed on Thursday, has so far received a whopping response from investors. Till 4:55 pm on the final day ...
The proceeds from the IPO are slated for plant improvements and automation, signaling Smithfield's commitment to enhancing operational efficiency and expanding its packaged-food segment. Metsera Inc., ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results